GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Total Debt per Share

Accelerated Pharma (Accelerated Pharma) Total Debt per Share : $0.71 (As of Mar. 2017)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Total Debt per Share?

$0.71 (As of Mar. 2017)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Accelerated Pharma's Total Debt Per Share for the quarter that ended in Mar. 2017 was $0.71.


Accelerated Pharma Total Debt per Share Historical Data

The historical data trend for Accelerated Pharma's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Total Debt per Share Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
Total Debt per Share
- 0.41 0.67

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Total Debt per Share Get a 7-Day Free Trial - 0.52 0.64 0.67 0.71

Accelerated Pharma Total Debt per Share Calculation

Accelerated Pharma's Total Debt Per Share for the fiscal year that ended in Dec. 2016 is calculated as:

Accelerated Pharma's Total Debt Per Share for the quarter that ended in Mar. 2017 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accelerated Pharma Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerated Pharma (Accelerated Pharma) Business Description

Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines